InVivoMAb recombinant Flt-3L-Ig (hum/hum), 5 mg and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0475965-V3
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $1,702
About this award
Bio X Cell has been awarded contract A207_PO-0475965-V3 by the University of Virginia, effective September 26, 2026. The contract encompasses the supply of specialized recombinant immunological reagents with a cumulative value of $1,702.40. The primary deliverables include InVivoMAb recombinant Flt-3L-Ig (human/human) at 5 milligrams per unit, with an order quantity of 1,246 units, and InVivoMAb recombinant human Immunoglobulin G1 Fc at 5 milligrams per unit, with an order quantity of 456 units.
The contract represents a procurement of research-grade biological products intended for delivery to the University of Virginia as the buyer and end-user. These monoclonal antibody and recombinant protein products are commonly utilized in immunological research and therapeutic development applications. The line item unit pricing is established at one dollar per unit across both product categories, with deliverables designated for performance at the buyer's location in Virginia.
Line items
| Item | Total |
|---|---|
| InVivoMAb recombinant Flt-3L-Ig (hum/hum), 5 mg | $1,246.00 |
| InVivoMAb recombinant human IgG1 Fc, 5 mg | $456.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0475965-V3?
Contract A207_PO-0475965-V3 was awarded to Bio X Cell by University of Virginia on September 26, 2026.
How much is contract A207_PO-0475965-V3 worth?
Its cumulative value is $1,702.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award